LV12067A - 17B-N-vienaizvietota-karbamoil-4-aza-5alfa-androst-1-en-3-onu pielietojums medikamenta razosanai - Google Patents

17B-N-vienaizvietota-karbamoil-4-aza-5alfa-androst-1-en-3-onu pielietojums medikamenta razosanai

Info

Publication number
LV12067A
LV12067A LV980034A LV980034A LV12067A LV 12067 A LV12067 A LV 12067A LV 980034 A LV980034 A LV 980034A LV 980034 A LV980034 A LV 980034A LV 12067 A LV12067 A LV 12067A
Authority
LV
Latvia
Prior art keywords
androst
aza
medicament
manufacture
monosubstituted carbamoyl
Prior art date
Application number
LV980034A
Other languages
English (en)
Other versions
LV12067B (lv
Inventor
Glenn J Gormley
Elizabeth Stoner
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of LV12067A publication Critical patent/LV12067A/lv
Publication of LV12067B publication Critical patent/LV12067B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LVP-98-34A 1991-12-17 1998-03-03 17beta-n-vienaizvietota-karbamoil-4-aza-5-alfa-androst-1-ēn-3-onu pielietojums medikamenta ražošanai LV12067B (lv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80851091A 1991-12-17 1991-12-17

Publications (2)

Publication Number Publication Date
LV12067A true LV12067A (lv) 1998-06-20
LV12067B LV12067B (lv) 1998-08-20

Family

ID=25198988

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-98-34A LV12067B (lv) 1991-12-17 1998-03-03 17beta-n-vienaizvietota-karbamoil-4-aza-5-alfa-androst-1-ēn-3-onu pielietojums medikamenta ražošanai

Country Status (6)

Country Link
US (2) US6268376B1 (lv)
EP (1) EP0547691B1 (lv)
JP (1) JP2538489B2 (lv)
CA (1) CA2084799C (lv)
DE (1) DE69218364T2 (lv)
LV (1) LV12067B (lv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2084799C (en) 1991-12-17 2003-01-28 Glenn J. Gormley Method of prevention of prostatic carcinoma with 17 beta-n-monosubstituted-carbamoyl-4-aza-5 alpha-androst-1 -en-3-ones
EP0547687A1 (en) * 1991-12-18 1993-06-23 Merck & Co. Inc. 17B-N-Substituted adamantyl/norbonanyl carbamoyl-4-aza-5a-and-rost-1-en-3-ones and androstan-3 ones
US5710275A (en) * 1992-05-20 1998-01-20 Merck & Co., Inc. 7β-substituted-4-aza-5α-androstan-3-ones as 5α-reductase inhibitors
EP0748221B1 (en) * 1993-11-04 1999-04-14 Merck & Co. Inc. 7-substituted-4-aza-steroid derivatives as 5-alpha- reductase inhibitors
US6177404B1 (en) 1996-10-15 2001-01-23 Merck & Co., Inc. Conjugates useful in the treatment of benign prostatic hyperplasia
US6093722A (en) 1997-02-26 2000-07-25 Sankyo Company, Limited Method for treating prostate cancer
US6645974B2 (en) * 2001-07-31 2003-11-11 Merck & Co., Inc. Androgen receptor modulators and methods for use thereof
KR100872722B1 (ko) * 2002-06-28 2008-12-05 주식회사 중외제약 피나스테라이드의 제조방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR830000085B1 (ko) * 1978-04-13 1983-02-08 제임스 에프. 너우톤 5α-환원효소 억제제로서 유용한 4-아자-17-치환-5α-안드로스탄-3-온류의 제조방법
AU527030B2 (en) 1978-04-13 1983-02-10 Merck & Co., Inc. 4-aza-17-substituted-5a-androstan-3-ones
US4760071A (en) * 1984-02-27 1988-07-26 Merck & Co., Inc. 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors
ZA851426B (en) * 1984-02-27 1986-10-29 Merck & Co Inc 17 beta-n-monosubstituted carbamoyl-4-aza-5 alpha-androst-1-en-3-ones as 5 alpha reductase inhibitors
US5049562A (en) 1984-02-27 1991-09-17 Merck & Co., Inc. 17β-acyl-4-aza-5α-androst-1-ene-3-ones as 5α-reductase inhibitors
GB8505862D0 (en) 1985-03-07 1985-04-11 Erba Farmitalia Steroidic 5alpha-reductase inhibitors
US4845104A (en) * 1986-11-20 1989-07-04 Merck & Co., Inc. Oxidized analogs of 17β-N-monosubstituted-carbamoyl-4-aza-5-α-androstan-3-ones
US4888336A (en) 1987-01-28 1989-12-19 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors
DE3888378T2 (de) * 1987-04-03 1994-09-29 Merck & Co Inc Behandlung von Prostatacarcinoma mit 17-beta-n-monosubstituierten-Carbamoyl-4-aza-5-alpha-Androst-1-en-3-onen.
US5021575A (en) 1989-11-13 1991-06-04 Merck & Co., Inc. Method for introducing a 1,2 double bond into azasteroids
GB9002922D0 (en) 1990-02-09 1990-04-04 Erba Carlo Spa 17 beta-substituted-4-aza-5 alpha-androstan-3-one derivatives and process for their preparation
EP0462662A3 (en) * 1990-06-20 1992-08-19 Merck & Co. Inc. 17beta-n-monosubstituted adamantyl/norbornanyl carbamoyl-4-aza-5alpha-androst-1-en-3-ones and androstan-3-ones
US5300294A (en) 1990-06-27 1994-04-05 Smithkline Beecham Corporation Method of treating prostatic adenocarcinoma
IE76452B1 (en) * 1990-10-29 1997-10-22 Sankyo Co Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use
CA2084799C (en) 1991-12-17 2003-01-28 Glenn J. Gormley Method of prevention of prostatic carcinoma with 17 beta-n-monosubstituted-carbamoyl-4-aza-5 alpha-androst-1 -en-3-ones
EP0547687A1 (en) 1991-12-18 1993-06-23 Merck & Co. Inc. 17B-N-Substituted adamantyl/norbonanyl carbamoyl-4-aza-5a-and-rost-1-en-3-ones and androstan-3 ones

Also Published As

Publication number Publication date
LV12067B (lv) 1998-08-20
US20010049376A1 (en) 2001-12-06
JP2538489B2 (ja) 1996-09-25
DE69218364T2 (de) 1997-09-25
CA2084799C (en) 2003-01-28
US6268376B1 (en) 2001-07-31
EP0547691B1 (en) 1997-03-19
DE69218364D1 (de) 1997-04-24
CA2084799A1 (en) 1993-06-18
US6432971B2 (en) 2002-08-13
JPH05255381A (ja) 1993-10-05
EP0547691A1 (en) 1993-06-23

Similar Documents

Publication Publication Date Title
BR9200984A (pt) Inalador
FI107883B (fi) Inhalointilaite
DE69122118D1 (de) Inhaliergerät
FI921060A (fi) Farmaceutiska aerosolformuleringar
FI922958A (fi) Farmaceutisk sammansaettning
FI922252A (fi) Farmaceutisk sammansaettning
FI922316A (fi) Farmaceutisk sammansaettning
DE69124516D1 (de) Katheter
DK0616523T3 (da) Lægemidler
NO923127L (no) Farmasoeytisk kombinasjonsformulering
DE69222622D1 (de) Spritze
NO923859D0 (no) Medikament
DK0510687T3 (da) Infusionspræparation
IT1296786B1 (it) Sedia
DE69227647D1 (de) Medizinischer Schlauch
FI943581A (fi) Ruisku
LV12067A (lv) 17B-N-vienaizvietota-karbamoil-4-aza-5alfa-androst-1-en-3-onu pielietojums medikamenta razosanai
FI930674A0 (fi) Terapeutiska aemnen
FI931071A0 (fi) Terapeutiska aemnen
FI920701A (fi) Anordning foer terapeutisk tryckbehandling
KR920021041U (ko) 세척기
NO924553D0 (no) Avstembar mikroboelgeoscillator
NO942783D0 (no) Spröyte
KR930006241U (ko) 환자용 벼개
SE9103070D0 (sv) New use